• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Axonics Buys Contura to Expand to Stress Urinary Incontinence

    Nurx Appoints Chief Medical Officer

    Median Technologies, UC San Diego to Partner on AI-Based Medical Imaging Technology

    Novel Heart Failure Treatment Technology Scores Positive Trial Results

    New COVID-19 Saliva Test Also Can Detect Variants and Flu Viruses
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Rethink Your Medtech ASC Strategy, Part 1

    Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

    Tips for Reigniting Your MDR/IVDR Preparation

    Three Major Innovation Opportunities for Biomedical Textiles

    Use Vertical Integration to Increase Productivity, Drive Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Forefront Medical Technology

    Qosina Corp.

    FUTEK Advanced Sensor Technology Inc.

    K-Tube Technologies

    Spectrum Plastics Group
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Grant Funding Works and How It Can Help

    Refurbished Medical Equipment Testing and Certification Under the NEC

    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Forefront Medical Technology

    Unicep

    Medicoil

    K-Tube Technologies

    FUTEK Advanced Sensor Technology Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Intersect ENT Touts Publication of a Pooled Analysis of the SINUVA Sinus Implant for Nasal Polyps

    Pooled analysis of the RESOLVE and RESOLVE II studies provides Level 1a clinical evidence.

    Related CONTENT
    • Intersect ENT Appoints New CEO
    • FDA Shares Progress on Efforts to Increase Transparency in Medical Device Reporting
    • A Breakthrough for the Nightmarish Effects of PTSD
    • The App Teaching Anorexics to Eat Again
    • BIOTRONIK's Orsiro Demonstrates Unique Benefits in Small Vessels
    Business Wire07.23.19
    Intersect ENT Inc., a company dedicated to transforming care for patients with ear, nose and throat conditions, announced publication of a pooled analysis of the RESOLVE and RESOLVE II randomized controlled trials (RCT). The results provide level 1a clinical evidence supporting the use of the SINUVA (mometasone furoate) Sinus Implant for management of patients with recurrent nasal polyps in adult patients who have had previous ethmoid sinus surgery.
     
    The analysis included 375 patients with chronic sinusitis and nasal polyps who were candidates for revision endoscopic sinus surgery (RESS) because of persisting symptoms of nasal obstruction/congestion and recurrent bilateral nasal polyps (non-cancerous tissue growth) despite ongoing topical steroid therapy and a recent course of systemic steroids. Patients were randomized to undergo an in-office bilateral placement of SINUVA in the ethmoid sinuses under local anesthesia (treatment group) or an in-office bilateral sham procedure (control group). All patients were required to use mometasone furoate nasal spray (MFNS) once daily. All study patients were blinded during the baseline procedure and each follow-up endoscopic examination.
     
    The pooled analysis met all four efficacy endpoints, demonstrating a decrease in nasal obstruction/congestion score (p=0.0095), bilateral polyp grade (p=0.0008) and ethmoid sinus obstruction (p<0.0001) at 90 days in SINUVA patients compared to the control group on MFNS alone. Additionally, results revealed a 59 percent reduction in the proportion of SINUVA patients who were still indicated for RESS at day 90 compared to a 31 percent reduction among patients in the control group (p<0.0001). Only one patient (0.4 percent) experienced an implant-related serious adverse event (epistaxis).
     
    “The findings of this analysis reveal the favorable role SINUVA can play in the management of recurrent nasal polyps in patients who have had a previous sinus surgery,” said Pablo Stolovitzky, M.D., of ENT of Georgia in Atlanta, lead author of the study. “These data provide clinical evidence that SINUVA—administered through a quick and simple office procedure—offers significant benefits for patients, reducing polyp growth and nasal obstruction, and ultimately, reducing the need for repeat surgeries.”
     
    SINUVA was approved by the U.S. Food and Drug Administration (FDA) in December 2017. Placed during a routine office visit under local or topical anesthesia, SINUVA is designed to deliver an anti-inflammatory steroid directly to the site of disease for an extended period of time (up to 90 days) following placement into the sinus cavity.
     
    “We are very pleased to see these strong study findings added to the foundational pool of data supporting the use of SINUVA,” said Lisa Earnhardt, president and CEO, Intersect ENT. “We are proud that this data provides further evidence for ENTs seeking improved outcomes for patients with nasal polyps and supports SINUVA as a favorable alternative to revision endoscopic sinus surgery.”
     
    RESOLVE was a double-blind RCT in 100 adult patients with chronic rhinosinusitis and nasal polyps, who had a previous sinus surgery and were indicated for revision endoscopic sinus surgery because they presented with recurrent nasal obstruction/congestion symptoms and recurrent bilateral sinus obstruction due to nasal polyps. The study evaluated the safety and efficacy of SINUVA to improve symptoms of nasal obstruction/congestion and reduce nasal polyps over three months. RESOLVE showed positive trends and an acceptable safety profile but did not meet its efficacy endpoints. The reduction in nasal obstruction/congestion score and bilateral polyp grade from baseline to day 90 reached statistical significance in a subset of patients with a higher polyp burden (grade 2 or higher on each side).
     
    RESOLVE II was a double-blind RCT in 300 adult patients with chronic rhinosinusitis and nasal polyps who had a previous sinus surgery but were indicated for revision endoscopic sinus surgery because they presented with refractory symptoms of nasal obstruction/congestion and recurrent bilateral nasal polyps. The study evaluated the safety and efficacy of SINUVA over three months. Primary efficacy endpoints were a change in nasal obstruction/congestion score from baseline to 30 days and in bilateral polyp grade from baseline to 90 days. The SINUVA treatment group included 201 randomized patients who underwent bilateral placement of SINUVA in the ethmoid sinuses. Ninety-nine patients were randomized to the control group where they received a sham procedure. Patients receiving SINUVA demonstrated statistical improvements compared to the control group across multiple prespecified primary and secondary efficacy endpoints.
     
    Steroid releasing implants provide targeted delivery of an anti-inflammatory steroid directly to the site of disease. Placed during a routine doctor’s office visit with local or topical anesthesia, the SINUVA (mometasone furoate) Sinus Implant is designed to deliver a treatment for nasal polyp disease for adults who have had prior ethmoid sinus surgery. The American Rhinologic Society (ARS) endorsed the utilization of drug eluting sinus implants in 2016, citing the number of well-controlled studies on drug-eluting implants in the paranasal sinuses.
     
    Intersect ENT is dedicated to transforming ear, nose and throat care by providing clinically meaningful therapies to physicians and patients. The company’s steroid releasing implants are designed to provide mechanical spacing and deliver targeted therapy to the site of disease. In addition, Intersect ENT is continuing to expand its portfolio of products based on the company’s unique localized steroid releasing technology and is committed to broadening patient access to less invasive and more cost-effective care.
     
    Intersect ENT is a registered trademark and SINUVA is a trademark of Intersect ENT Inc.
     
    Related Searches
    • implant
    • change
    • surgery
    • tissue
    Suggested For You
    Intersect ENT Appoints New CEO Intersect ENT Appoints New CEO
    FDA Shares Progress on Efforts to Increase Transparency in Medical Device Reporting FDA Shares Progress on Efforts to Increase Transparency in Medical Device Reporting
    A Breakthrough for the Nightmarish Effects of PTSD A Breakthrough for the Nightmarish Effects of PTSD
    The App Teaching Anorexics to Eat Again The App Teaching Anorexics to Eat Again
    BIOTRONIK BIOTRONIK's Orsiro Demonstrates Unique Benefits in Small Vessels
    Intersect ENT Intersect ENT's CEO Steps Down
    FDA Approves Device to Help Increase Access to More Lungs for Transplant FDA Approves Device to Help Increase Access to More Lungs for Transplant
    A New, Tailored Review Framework for Artificial Intelligence-Based Devices A New, Tailored Review Framework for Artificial Intelligence-Based Devices
    Smith & Nephew to Purchase Leaf Healthcare Smith & Nephew to Purchase Leaf Healthcare
    FDA to Modernize Mammography Services and Improve Their Quality FDA to Modernize Mammography Services and Improve Their Quality
    FDA Warns J&J and Sientra for Breast Implant Compliance Failure FDA Warns J&J and Sientra for Breast Implant Compliance Failure
    FDA to Closely Examine Surgical Stapler Risks FDA to Closely Examine Surgical Stapler Risks
    Intersect ENT Enrolls First Patient in ASCEND Study of Investigational Drug-Coated Sinus Balloon Intersect ENT Enrolls First Patient in ASCEND Study of Investigational Drug-Coated Sinus Balloon

    Related Breaking News

    • Axonics Buys Contura to Expand to Stress Urinary Incontinence

      Axonics Buys Contura to Expand to Stress Urinary Incontinence

      Gains Bulkamid, a urethral bulking agent for women.
      Sam Brusco, Associate Editor 03.01.21

    • Nurx Appoints Chief Medical Officer

      Nurx Appoints Chief Medical Officer

      Taps Dr. Jennifer Peña during a rapid period of growth.
      Charles Sternberg, Assistant Editor 03.01.21

    • Median Technologies, UC San Diego to Partner on AI-Based Medical Imaging Technology

      Median Technologies, UC San Diego to Partner on AI-Based Medical Imaging Technology

      The collaboration will enable Median to work on a large NASH patient cohort to lead the validation of its iBiopsy’s AI technology.
      Michael Barbella, Managing Editor 03.01.21


    • Cardiovascular
      Novel Heart Failure Treatment Technology Scores Positive Trial Results

      Novel Heart Failure Treatment Technology Scores Positive Trial Results

      All patients treated with Vascular Dynamics' MobiusHD Device showed improvement.
      Michael Barbella, Managing Editor 03.01.21

    • New COVID-19 Saliva Test Also Can Detect Variants and Flu Viruses

      New COVID-19 Saliva Test Also Can Detect Variants and Flu Viruses

      Emergency Use Authorization application filed with the FDA.
      Michael Barbella, Managing Editor 03.01.21

    • Chronic Disease
      January AI Raises $8.8 Million in New Funding

      January AI Raises $8.8 Million in New Funding

      New technology can predict users’ glycemic response to over 16 million foods in its proprietary atlas.
      Charles Sternberg, Assistant Editor 02.26.21


    • FDA Clears Ava Fertility Tracking Wearable Device

      FDA Clears Ava Fertility Tracking Wearable Device

      The wearable is clinically proven as effective as LH tests in predicting ovulation—and with more fertile days detected.
      Michael Barbella, Managing Editor 02.26.21

    • First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System

      First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System

      The product received CE Mark approval in January.
      Michael Barbella, Managing Editor 02.26.21

    • Digital Health
      Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably

      Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably

      The FDA’s five-part action plan is expected to drive the surge.
      Michael Barbella, Managing Editor 02.26.21


    • Japan to Lead APAC Assisted Reproductive Technology Devices Market

      Japan to Lead APAC Assisted Reproductive Technology Devices Market

      Sector forecast to grow 2.1 percent annually this decade.
      Michael Barbella, Managing Editor 02.25.21

    • Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification

      Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification

      Meet the highest quality standards for manufacturing.
      Charles Sternberg, Assistant Editor 02.25.21

    • Cardiovascular
      FDA Breakthrough Device Designation Given to MI Transcatheter Heart Pump

      FDA Breakthrough Device Designation Given to MI Transcatheter Heart Pump

      Puzzle Medical Device's ModulHeart helps patients avoid open-heart surgery and reduces blood trauma.
      Michael Barbella, Managing Editor 02.25.21


    • Canada Authorizes COVID-19 Diagnostic Assay That Boosts Virus Testing Efficiency

      Canada Authorizes COVID-19 Diagnostic Assay That Boosts Virus Testing Efficiency

      The product is compatible with Thermo Fisher Scientific's Amplitude platform.
      Michael Barbella, Managing Editor 02.25.21

    • Digital Health
      Terumo to Purchase Predictive Analytics Firm Health Outcomes Sciences

      Terumo to Purchase Predictive Analytics Firm Health Outcomes Sciences

      Will enable personalized, predictive insights at the point of care.
      Sam Brusco, Associate Editor 02.24.21

    • Abiomed Leader Michael Minogue Named AdvaMed Board Chairman

      Abiomed Leader Michael Minogue Named AdvaMed Board Chairman

      He succeeds Stryker Chairman and CEO Kevin Lobo.
      Sam Brusco, Associate Editor 02.24.21


    Trending
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • 7 Considerations For Designing Medical Device Mechanisms
    • Common Issues And Their Solutions In Health Application Development
    Breaking News
    • Axonics Buys Contura to Expand to Stress Urinary Incontinence
    • Nurx Appoints Chief Medical Officer
    • Median Technologies, UC San Diego to Partner on AI-Based Medical Imaging Technology
    • Novel Heart Failure Treatment Technology Scores Positive Trial Results
    • New COVID-19 Saliva Test Also Can Detect Variants and Flu Viruses
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • Seeking a Revolution in Clinical Care Through AI
    • Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit
    • Addition by Subtraction: The Latest of Machining for Medtech
    • Innovation Incubators: An R&D Roundtable
    • Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands
    Gencor Announces Positive Results in VeriSperse Bioavailability Study
    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC
    Coatings World

    Latest Breaking News From Coatings World

    Mule-Hide Products Co. Promotes Steven Litaker to Territory Manager
    Terra Firma, Wanhua Announce New Distribution Partnership
    Gelest CEO Elected to National Academy of Engineering
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Axonics Buys Contura to Expand to Stress Urinary Incontinence
    Nurx Appoints Chief Medical Officer
    Median Technologies, UC San Diego to Partner on AI-Based Medical Imaging Technology
    Contract Pharma

    Latest Breaking News From Contract Pharma

    J&J’s Single-Dose COVID-19 Vax Issued EUA
    Icon to Acquire PRA Health Sciences
    Phlow Corp. and USP Form Alliance
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Universal Engraving Announces New President
    Raw Sugar Living Expands to Target with New Collection
    Supporting Female Beauty Brand Founders on International Women's Day
    Happi

    Latest Breaking News From Happi

    ACI and CBC Launch Webpage About ‘Quats’
    L’Occitane Launches Hand Cream Inspired by Women
    Kiehl’s Partners with Gyrl Wonder
    Ink World

    Latest Breaking News From Ink World

    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI analyzes pandemic's effect on label industry in new report
    UEI names Ross Hutchison president
    Schreiner MediPharm and AARDEX partner for clinical trials
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    U.S. Nonwovens Rebrands as Radienz Living
    What You’re Reading on Nonwovens-Industry.com
    Texas Medical Technology Partners with My Protect Kit
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Pandemic Pain: NuVasive's 2020 Sales Fall 10 Percent
    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login